Previous PDL Practice Alert
Next I strongly oppose the idea of hangover IV clinics: supplier

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.

1 Comment

  1. Drugby

    I think it is fair to say the evidence on the clinical benefits of glucosamine/chondroitin is conflicting. A recent article in Arthritis Care & Research adds to the body of evidence. Importantly this study was conducted over 6 years follow-up. Glu/CS significantly reduced the cartilage volume loss in the global knee, associated with the lateral compartment. The protective effect at 6 years was significant in participants exposed to two or more years of treatment.

Leave a reply